Neumora Therapeutics, Inc. Reported Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
March 07, 2024 at 07:00 am EST
Neumora Therapeutics, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 108.73 million compared to USD 28.15 million a year ago. Basic loss per share from continuing operations was USD 0.71 compared to USD 0.99 a year ago.
For the full year, the company reported net loss was USD 235.93 million compared to USD 130.9 million a year ago. Basic loss per share from continuing operations was USD 3.63 compared to USD 4.81 a year ago.